---
figid: PMC6330346__fphar-09-01520-g003
figtitle: Rapamycin inhibits the de-differentiation of vascular smooth muscle cells
organisms:
- Oryctolagus cuniculus
- Sus scrofa
- Candida dubliniensis
- herbal medicine
- Homo sapiens
- Mus musculus
- Streptomyces hygroscopicus
pmcid: PMC6330346
filename: fphar-09-01520-g003.jpg
figlink: /pmc/articles/PMC6330346/figure/F3/
number: F3
caption: Rapamycin inhibits the de-differentiation of vascular smooth muscle cells.
  Rapamycin suppresses the de-differentiation of vascular smooth muscle cells by inhibiting
  the activation of mTOR and S6K1, activating PI3K/AKT pathways, inhibiting PDGF pathway
  and the formation of FGFR-1/FRS2/mTOR complex. In addition, rapamycin inhibits the
  synthesis of hyaluronan through decreasing HAS and the secretion of VEGF. The solid
  lines with arrow and notation ↑ indicate increase or activation, and lines without
  arrows indicate decrease or suppression. VSMC, vascular smooth muscle cell; S6K1,
  ribosomal protein S6 kinase 1; mTOR, mammalian target of rapamycin; IFN-γ, interferon-γ;
  IL-1β, interleukin-1β; VEGF, vascular endothelial growth factor; RAPA, rapamycin;
  HAS, hyaluronan synthase; α-SMA, α-smooth muscle actin; SM-MHC, smooth muscle-myosin
  heavy chain; FGFR1, fibroblast growth factor receptor 1; FRS2, fibroblast growth
  factor receptor substrate 2; FGF, fibroblast growth factor; IGF, insulin-like growth
  factor; PDGF, platelet-derived growth factor.
papertitle: 'Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic
  Effects and Its Clinical Application.'
reftext: Yandong Liu, et al. Front Pharmacol. 2018;9:1520.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9647337
figid_alias: PMC6330346__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Oryctolagus cuniculus
- Mus musculus
- Sus scrofa
redirect_from: /figures/PMC6330346__F3
ndex: 9e31f020-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6330346__fphar-09-01520-g003.html
  '@type': Dataset
  description: Rapamycin inhibits the de-differentiation of vascular smooth muscle
    cells. Rapamycin suppresses the de-differentiation of vascular smooth muscle cells
    by inhibiting the activation of mTOR and S6K1, activating PI3K/AKT pathways, inhibiting
    PDGF pathway and the formation of FGFR-1/FRS2/mTOR complex. In addition, rapamycin
    inhibits the synthesis of hyaluronan through decreasing HAS and the secretion
    of VEGF. The solid lines with arrow and notation ↑ indicate increase or activation,
    and lines without arrows indicate decrease or suppression. VSMC, vascular smooth
    muscle cell; S6K1, ribosomal protein S6 kinase 1; mTOR, mammalian target of rapamycin;
    IFN-γ, interferon-γ; IL-1β, interleukin-1β; VEGF, vascular endothelial growth
    factor; RAPA, rapamycin; HAS, hyaluronan synthase; α-SMA, α-smooth muscle actin;
    SM-MHC, smooth muscle-myosin heavy chain; FGFR1, fibroblast growth factor receptor
    1; FRS2, fibroblast growth factor receptor substrate 2; FGF, fibroblast growth
    factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IGF1
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - FGFR1
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - PDGFRB
  - PDGFRA
  - MTOR
  - FRS2
  - RPS6KB1
  - AKT1
  - AKT2
  - AKT3
  - CDKN1A
  - TRERF1
  - HAS1
  - MYH11
  - ACTA1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Il1b
  - Vegfa
  - Fgfr1
  - Pdgfrb
  - Mtor
  - Frs2
  - pk
  - Rps6kb1
  - Akt1
  - Cdkn1a
  - Trerf1
  - Has1
  - Myh11
  - Acta2
  - Pik3r1
  - IL1B2
  - Cancer
---
